| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp. | Director | Class A Common Stock | 41,506 | $2,906,250 | $70.02 | 18 Jun 2025 | Direct |
| GeneDx Holdings Corp. | Director | Restricted Stock Unit | 12,924 | $365,878 | $28.31 | 26 Jun 2024 | Direct |
| Fluent, Inc. | Director | Common Stock | 90,341 | $150,869 | $1.67 | 18 Jun 2025 | Direct |
| Cocrystal Pharma, Inc. | Director | Warrants | 40,000 | $55,599 | $1.39 | 28 Oct 2025 | Direct |
| Cocrystal Pharma, Inc. | Director | Common Stock | 31,400 | $39,268 | $1.25 | 28 Oct 2025 | Direct |
| ASENSUS SURGICAL, INC. | Director | Common Stock | 0 | $0 | $0.2500 | 22 Aug 2024 | Direct |
| OPKO HEALTH, INC. | Director | Stock Option (Right to Buy) | 60,000 | 23 Apr 2025 | Direct | ||
| Cocrystal Pharma, Inc. | Director | Stock Options (Right to Buy) | 16,410 | 09 Jan 2026 | Direct | ||
| GeneDx Holdings Corp. | Director | Restricted Stock Unit | 0 | 18 Jun 2025 | Direct | ||
| GP STRATEGIES CORP | Director | Common Stock | 0 | $20.85 | 14 Oct 2021 | Direct |